Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03939819 · ClinicalTrials.gov registry record · NA

Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT03939819: Completed NA study, sponsored by Emory University.

NCT03939819 is a NA study that has completed, run by Emory University. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03939819, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

This study aims to compare the difference in staple usage and post-operative GERD (heartburn) between patients that had an endoscope used versus patients that had a suction calibration system used on them during "laparoscopic sleeve gastrectomy" (LSG).

Primary Outcome

Staple usage will be recorded during the weight loss surgery procedure.

Interventions

  • DEVICE ViSiGi® 3D suction calibration device
  • DEVICE Esophagogastroduodenoscopy (EGD) calibration

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2019-07-30
Est. Completion 2022-02-02
Phase NA
Emory University

1,208 total trials

What the finished NCT03939819 record still lists

NCT03939819 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which ViSiGi® 3D suction calibration device is the first listed.

NCT03939819 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03939819 about?

NCT03939819 is a clinical study titled "Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy". This study aims to compare the difference in staple usage and post-operative GERD (heartburn) between patients that had an endoscope used versus patients that had a suction calibration system used on them during "laparoscopic sleeve gastrectomy" (LSG).

What is the current status of trial NCT03939819?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2019-07-30. Estimated completion is 2022-02-02.

What interventions are being tested in trial NCT03939819?

The interventions under investigation include: ViSiGi® 3D suction calibration device (DEVICE), Esophagogastroduodenoscopy (EGD) calibration (DEVICE).

Who is sponsoring clinical trial NCT03939819?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03939819's enrollment target sits among peer trials

106 830th of 2000 higher than 1,167 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03181048 · 106 participants · NA

    Clinical Trial of Concomitant Hip Arthroscopy During PAO

  • NCT04682158 · 106 participants · Phase 2

    Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

  • NCT04724018 · 106 participants · Phase 1

    Sacituzumab Govitecan Plus EV in Metastatic UC

  • NCT04798274 · 106 participants · NA

    Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03939819, the US trial registry maintained by the National Library of Medicine. NCT03939819 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.